MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 65 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSFG, LLC | 160 | $2 | 0.00% |
| MetLife Investment Management, LLC | 5,610 | $69,171 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| LAZARD ASSET MANAGEMENT LLC | 3,123 | $38 | 0.00% |
| GROUP ONE TRADING, L.P. | 4,528 | $55,830 | 0.00% |
| Legal & General Group Plc | 1,286 | $15,856 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 251,585 | $3,102,502 | 0.00% |
| STATE STREET CORP | 191,844 | $2,365,437 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 8,207 | $101 | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 15 | $185 | 0.00% |
| DEUTSCHE BANK AG\ | 910 | $11,220 | 0.00% |
| CITIGROUP INC | 24 | $296 | 0.00% |
| Nuveen Asset Management, LLC | 13,719 | $169,155 | 0.00% |
| GOLDMAN SACHS GROUP INC | 34,953 | $430,971 | 0.00% |
| MORGAN STANLEY | 93,177 | $1,148,873 | 0.00% |
| COMERICA BANK | 500 | $6,165 | 0.00% |
| AMALGAMATED BANK | 1,587 | $20 | 0.00% |
| BlackRock Inc. | 690,817 | $8,517,775 | 0.00% |
| Horrell Capital Management, Inc. | 50 | $1 | 0.00% |
| Bank of New York Mellon Corp | 99,703 | $1,229,338 | 0.00% |
External links
This page lists MERRIMACK PHARMACEUTICALS IN's shareholders in Q3 2023. To view MERRIMACK PHARMACEUTICALS IN's shareholder history, click here.